7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Corticobasal Degeneration

Corticobasal degeneration is a rare progressive brain disorder. Learn about its symptoms, possible causes, how it is diagnosed, and current treatment options.

Neurology & NeurosurgeryICD-10: G31.85
Doctor consulting with elderly patient in a medical office.
Condition at a Glance
ICD-10 codeG31.85
SpecialtyNeurology & Neurosurgery
Specialists1 doctor available

Quick answer

Corticobasal degeneration is a rare, progressive brain disorder in which an abnormal form of the tau protein builds up in nerve cells of the cerebral cortex and basal ganglia. It causes one-sided stiffness, clumsiness, involuntary movements, and problems with language and thinking, usually starting after age sixty. There is no cure; treatment aims to relieve symptoms.

What is corticobasal degeneration?

Corticobasal degeneration (often shortened to CBD) is a rare, progressive brain disorder. Progressive means it slowly gets worse over time. The condition damages nerve cells in two main areas of the brain: the cerebral cortex, which is the outer layer responsible for thinking, movement planning, and language, and the basal ganglia, which are deep structures that help control movement. The name comes from these two areas, cortex and basal ganglia.

Corticobasal degeneration belongs to a group of illnesses called tauopathies. In these conditions, a normal brain protein called tau folds abnormally and builds up inside nerve cells, gradually stopping them from working and eventually causing them to die. Progressive supranuclear palsy and some forms of frontotemporal dementia belong to the same group, which is one reason these conditions can look alike.

The disorder usually begins in later adult life, most often after the age of sixty, although it can start earlier. It affects men and women in roughly similar numbers. Because it is uncommon and its early signs can resemble Parkinson’s disease, stroke, or other conditions, many people live with symptoms for some time before the correct name is given to their illness. Neurologists, doctors who specialize in disorders of the brain and nerves, usually lead care for this condition, and in hospital groups such as Acibadem it is managed within the Neurology department.

Doctors sometimes distinguish between corticobasal syndrome, which describes the pattern of symptoms seen during life, and corticobasal degeneration, which refers to the specific tau-related brain changes that can only be confirmed by examining brain tissue after death. Not everyone with the syndrome turns out to have this exact underlying disease, and some people with the disease develop a different pattern of symptoms. This distinction matters for research but changes little about day-to-day care.

Corticobasal degeneration symptoms

Corticobasal degeneration symptoms vary a great deal from person to person. A hallmark feature is that problems often begin on one side of the body and remain worse on that side for a long time, even as the other side becomes involved. Symptoms fall broadly into movement problems and thinking or language problems, and either group may appear first.

Common movement-related symptoms include:

  • Stiffness (rigidity) in an arm or leg, usually on one side at first
  • Slowness of movement (bradykinesia), making everyday tasks take longer
  • Apraxia, which is difficulty carrying out learned, purposeful movements such as buttoning a shirt, using a comb, or waving, even though strength is preserved
  • Dystonia, meaning sustained muscle contractions that pull a hand or foot into an unusual, sometimes painful, position
  • Myoclonus, brief sudden jerks of a limb, often triggered by touch or movement
  • Alien limb phenomenon, where an arm or hand seems to move on its own or feels as if it does not belong to the person
  • Loss of fine sensation in a limb, such as trouble recognizing an object by touch alone
  • Problems with balance, unsteady walking, and falls
  • Tremor, which is less common and usually irregular rather than the rhythmic resting tremor typical of Parkinson’s disease

Thinking, behavior, and language symptoms may include:

  • Difficulty finding words, slow or effortful speech, or trouble forming sentences (aphasia)
  • Trouble planning, organizing, and problem solving
  • Difficulty with numbers, such as handling money
  • Changes in personality, such as apathy, irritability, or reduced social awareness
  • Difficulty judging where objects are in space, which can affect reaching, dressing, or reading
  • Trouble swallowing (dysphagia) as the condition advances

In the early stage, a person may notice only a clumsy or stiff hand, a subtle change in speech, or mild forgetfulness. Over several years, symptoms typically spread to the other side of the body and become more disabling. In later stages, walking without help, speaking clearly, and swallowing safely often become difficult, and people usually need substantial support with daily activities. The order in which symptoms appear and the speed of change differ widely, so no two people follow exactly the same course.

Causes and risk factors

Corticobasal degeneration causes are not fully understood. What is known is that the disease involves abnormal clumps of the tau protein inside nerve cells and supporting cells in the brain. In healthy cells, tau helps stabilize the internal skeleton that transports nutrients. In corticobasal degeneration, tau becomes chemically altered, folds incorrectly, and accumulates. Affected cells lose their function and die, and the regions of the brain they occupied gradually shrink.

Researchers do not yet know what triggers this process. Several points are widely accepted:

  • The condition is not infectious; it cannot be passed from person to person.
  • In the great majority of cases it is not inherited. Most people with the diagnosis have no family history of it.
  • Certain common variations in the gene that produces tau appear to slightly increase susceptibility in the general population, but they do not cause the disease on their own and are not routinely tested for.
  • Rare families with mutations in tau-related genes can develop conditions that resemble corticobasal degeneration, but these situations are unusual.
  • No specific diet, occupation, toxin, or head injury has been proven to cause the disorder.

The main recognized risk factor is age, since the condition almost always begins in middle or later adulthood. Beyond that, there are no lifestyle factors that have been clearly shown to raise or lower a person’s chance of developing it. If you have a relative with the condition, your own risk is generally thought to be only slightly, if at all, above that of the general population, although your doctor may suggest genetic counseling in the uncommon situation where several family members are affected.

Corticobasal degeneration diagnosis

Corticobasal degeneration diagnosis is made mainly on clinical grounds, which means it rests on a careful medical history and a detailed neurological examination rather than on a single laboratory test. During life, doctors can reach a diagnosis of probable or possible corticobasal syndrome; a definite diagnosis of the underlying disease can only be confirmed by examining brain tissue after death. This is why some people receive a working diagnosis that is revised as the illness evolves.

The evaluation usually includes:

  • Medical history: when symptoms began, which side of the body was affected first, how they have changed, and what medications have been tried.
  • Neurological examination: testing muscle tone, coordination, reflexes, sensation, eye movements, and the ability to carry out gestures and use tools, which helps detect apraxia and alien limb signs.
  • Neuropsychological testing: structured assessments of memory, language, attention, visual-spatial skills, and problem solving performed by a specialist psychologist.
  • Magnetic resonance imaging (MRI): a scan that uses magnetic fields to create detailed brain pictures. It may show shrinkage of specific regions, often more marked on one side, and helps rule out stroke, tumors, or other structural causes.
  • Nuclear medicine scans such as PET or SPECT: these show brain activity or dopamine function and may support the diagnosis or help distinguish it from Parkinson’s disease, though they cannot confirm it on their own.
  • Blood tests: used to exclude treatable conditions such as thyroid disease, vitamin deficiencies, or infections that can produce similar symptoms.
  • Trial of levodopa: a medication used in Parkinson’s disease. People with corticobasal degeneration typically show little or no lasting improvement, which is itself a useful clue.

Doctors compare the findings against published diagnostic criteria that describe the combination of movement and cognitive features expected in the condition. Because early features overlap with Parkinson’s disease, progressive supranuclear palsy, Alzheimer’s disease, and frontotemporal dementia, a movement disorder specialist or a memory specialist is often involved, and follow-up visits over months or years are frequently needed before the picture becomes clear. Research is ongoing into spinal fluid and blood markers of tau, but these are not yet standard tools for diagnosing corticobasal degeneration in routine care.

Corticobasal degeneration treatment options

At present there is no treatment that cures corticobasal degeneration or that has been shown to stop or slow the underlying loss of nerve cells. Corticobasal degeneration treatment therefore focuses on easing individual symptoms, preserving independence for as long as possible, preventing complications, and supporting quality of life. Care is usually best delivered by a team that includes a neurologist, therapists, nurses, and, when appropriate, palliative care specialists.

Medications are chosen symptom by symptom, and their benefits are often modest. Options your doctor may consider include:

  • Levodopa or other Parkinson’s medications for stiffness and slowness. Some people notice a small, temporary improvement, but many do not respond, and the drug is often stopped if it does not help.
  • Botulinum toxin injections into overactive muscles to relieve painful dystonia, reduce a clenched hand, or help with drooling.
  • Muscle relaxants such as baclofen for rigidity, used cautiously because they may cause drowsiness.
  • Anti-seizure medications such as clonazepam or levetiracetam to reduce myoclonic jerks.
  • Antidepressants for low mood, anxiety, or irritability, which are common and can significantly affect daily life.
  • Pain relievers when stiffness or abnormal postures cause discomfort.

Rehabilitation therapies are a central part of care:

  • Physical therapy helps maintain flexibility, strength, and balance, teaches safer ways to move, and reduces fall risk. Stretching can lessen the discomfort of dystonia.
  • Occupational therapy focuses on daily tasks such as dressing, eating, and writing, and on adapting the home with grab bars, raised seats, or specialized utensils.
  • Speech and language therapy supports clearer communication, introduces communication aids when speech becomes difficult, and assesses swallowing to reduce the risk of choking and chest infections.
  • Dietitian input helps maintain nutrition and hydration when swallowing changes, including advice on food textures.

Surgery has a limited role. Deep brain stimulation, an operation used in Parkinson’s disease, is generally not recommended for corticobasal degeneration because it has not been shown to help and may carry risks without benefit. In advanced stages, a feeding tube placed through the abdominal wall may be discussed if swallowing becomes unsafe; this is a personal decision that depends on the person’s wishes and overall situation.

Supportive and palliative care is appropriate from an early stage, not only at the end of life. It addresses comfort, emotional well-being, and planning for future care, and it supports family caregivers. Discussing preferences about future medical decisions while communication is still relatively easy can be valuable. Some people also choose to take part in clinical trials of experimental tau-targeting therapies; your neurologist can explain whether any are available and suitable.

Living with corticobasal degeneration and outlook

Corticobasal degeneration is a life-limiting condition. It progresses steadily over a period of years, and the rate of change differs from person to person. Some people remain relatively independent for several years, while others decline more quickly. As the disease advances, walking, speaking, and swallowing usually become increasingly difficult, and most people eventually need help with all daily activities. Serious complications in later stages are often related to swallowing problems, such as pneumonia caused by food or liquid entering the lungs, and to falls. Doctors cannot predict an individual’s course with certainty, and estimates given at diagnosis are general averages rather than personal forecasts.

Many practical steps can improve safety and comfort:

  • Remove trip hazards at home, improve lighting, and use walking aids or a wheelchair when advised, to reduce falls.
  • Follow swallowing advice closely, including sitting upright to eat and using recommended food textures.
  • Keep a regular routine and use written reminders, calendars, and simple communication cards.
  • Stay as physically and socially active as symptoms allow; gentle daily movement helps maintain flexibility.
  • Arrange regular reviews with the care team so that medications and equipment can be adjusted as needs change.

Caring for someone with this condition is demanding. Caregivers often benefit from respite services, support groups for rare neurological conditions, and counseling. Legal and financial planning, including decisions about power of attorney and advance care preferences, is easier when addressed early. Many families find that involving palliative care specialists helps them manage symptoms and make difficult decisions with more confidence.

Frequently asked questions

What are the first corticobasal degeneration symptoms people usually notice?

The earliest signs are often subtle and one-sided. Many people first notice a stiff, clumsy, or awkward hand or arm that has trouble with skilled tasks such as writing or using cutlery, even though the limb is not weak. Others first experience changes in speech, difficulty finding words, or problems with balance. Because these early symptoms resemble other conditions, an accurate diagnosis may take time, and your doctor may need to follow you over several visits.

Is corticobasal degeneration the same as Parkinson’s disease?

No, although the two conditions share some features such as stiffness and slowness, which is why corticobasal degeneration is sometimes called an atypical parkinsonian disorder. Key differences include the presence of apraxia and alien limb phenomenon, more prominent language and thinking problems, a lack of the typical resting tremor, and little or no lasting response to levodopa. The underlying brain changes also differ: Parkinson’s disease involves a protein called alpha-synuclein, whereas corticobasal degeneration involves tau.

What causes corticobasal degeneration, and can it run in families?

The exact corticobasal degeneration causes are unknown. The disease involves abnormal buildup of the tau protein in brain cells, but scientists have not identified what starts this process. In the vast majority of cases the condition is sporadic, meaning it occurs without a family history, and it is not passed directly from parent to child. Very rare familial forms linked to tau-related gene mutations exist, so if several relatives have similar conditions your doctor may suggest genetic counseling.

How is corticobasal degeneration diagnosis confirmed?

There is no single test that confirms the diagnosis during life. Doctors rely on a detailed history, a neurological examination, cognitive testing, and brain imaging such as MRI to identify the characteristic pattern and rule out other causes. The diagnosis is described as probable or possible corticobasal syndrome and may be revised as symptoms evolve. A definite diagnosis of the underlying disease is only possible through examination of brain tissue after death.

Is there a cure or effective corticobasal degeneration treatment?

There is currently no cure and no treatment proven to slow the disease. Corticobasal degeneration treatment focuses on relieving specific symptoms and maintaining function. This may include medications for stiffness, jerks, dystonia, or mood; botulinum toxin injections for painful muscle contractions; and physical, occupational, and speech therapy. Responses vary, and some medications help only a little or not at all. Research into therapies that target tau is ongoing, and your neurologist can advise whether clinical trials are an option.

How quickly does corticobasal degeneration progress?

Progression is gradual and usually measured in years, but the pace varies considerably between individuals. Symptoms typically spread from one side of the body to the other and become more disabling over time, eventually affecting walking, speech, and swallowing. Doctors cannot reliably predict how fast any one person will decline. Regular follow-up allows the care team to adjust support as needs change.

Can corticobasal degeneration be prevented?

There is no known way to prevent corticobasal degeneration, because its underlying cause has not been identified and no modifiable lifestyle factors have been clearly linked to it. General measures that support brain health, such as staying physically active, managing blood pressure and other vascular risks, and remaining socially engaged, are sensible for everyone but have not been shown to prevent this specific disease.

When to see a doctor

Anyone who develops persistent stiffness, clumsiness, or loss of skilled hand use on one side of the body, unexplained changes in speech or language, or new problems with balance should be evaluated by a doctor, as these features have many possible causes and some are treatable. Referral to a neurologist is usually appropriate when symptoms are progressive or do not have an obvious explanation.

For someone already living with corticobasal degeneration, the following warning signs need urgent medical attention:

  • Choking, coughing, or difficulty breathing during or after eating or drinking
  • Fever, new cough, or shortness of breath, which may indicate pneumonia
  • A fall with head injury, severe pain, or inability to move or bear weight on a limb
  • Sudden new weakness, facial drooping, or speech loss developing over minutes to hours, which could signal a stroke and requires emergency care
  • Signs of dehydration or very reduced food intake over several days
  • Sudden confusion, agitation, or drowsiness that is out of keeping with the person’s usual state
  • Severe, uncontrolled pain from muscle spasms or abnormal limb postures
  • Thoughts of self-harm or severe depression in the person or their caregiver

Less urgent but important reasons to arrange a review include increasing falls, weight loss, worsening swallowing, medication side effects, and caregiver exhaustion. Early attention to these problems can prevent complications and help maintain comfort and safety.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 13, 2026
See our medical review board →

Published: September 13, 2026Last updated: September 13, 2026
Update history
  • PublishedSeptember 13, 2026
  • Medical review approvedSeptember 13, 2026
  • Last content updateSeptember 13, 2026
References2
  1. ninds.nih.gov
  2. nhs.uk
Treatments

Treatments for This Condition

Departments

Care at Acibadem

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.